Trademark Alertz ®
Search
Trademark
Owner
Trademark: ACCELERATING INNOVATION IN NK CELL THERAPY 2025229
Word
ACCELERATING INNOVATION IN NK CELL THERAPY
ID
2025229
Trademark Type
Word
Status
Cancelled: Cancelled at the request of IB
Application Date
23 January 2019
Cancellation Date
07 March 2023
Owner(s)
Kiadis Pharma Intellectual Property B.V.
Service
Goods and Services:
Class 5
:
Pharmaceutical preparations for the treatment of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders
;
stem cells for medical purposes
;
living cells for medical use
;
biological preparations for the treatment of cancer
;
therapeutics utilizing NC cells for use in the treatment of cancer, autoimmune disease and infectious diseases
;
cell preparations, cellular vaccines and cellular biologics for the treatment of cancer and infectious diseases by autologous cell-based immunotherapy.
Class 42
:
Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies using natural killer cells
;
industrial research in the field of new pharmaceutical products and new cancer therapies
;
medical and veterinary research services in the nature of the manipulation of cells within a laboratory or research facility to enable natural killer cells to be used for medical or therapeutic purposes
;
scientific research in the development of new cancer therapies
;
scientific research in human and animal cell therapy
;
scientific research into preparations for manipulating and adapting human and animal cells
;
consultancy relating to all the aforesaid services
;
conducting research and clinical trials for others relating to the use and the engineering of natural killer cells and cancer treatment and therapy
;
medical and scientific research in the field of cancer treatment and diagnosis
;
data collection for others for research purposes, namely, the collection, testing and research of patient molecular and genomic data
;
collection and preservation of human and animal DNA for research purposes.
Class 44
:
Medical testing for diagnostic or treatment purposes in the field of cancer research
;
medical diagnostic testing, monitoring and reporting services
;
medical evaluation of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders
;
medical monitoring services
;
medical diagnostic, prognostic and theranostic screening and testing services
;
collection and preservation of DNA for medical purposes
;
consulting services in the nature of providing medical information
;
consulting services in the field of healthcare and cancer diagnoses
;
providing a website featuring health and healthcare information related to cancer, testing and screening
;
genetic testing for medical purposes
;
providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes
;
providing genetics assessments in the nature of genetic counseling
;
genetic testing for medical diagnostic purposes
;
genomic testing for medical diagnostic purposes
;
Gene analysis and sequencing and DNA analysis and sequencing for medical diagnostic purposes and veterinary diagnostics purposes
;
gene analysis and sequencing and DNA analysis and sequencing for use in cancer diagnosis and treatment
;
providing health and healthcare information related to cancer research, via a website.